Viewing StudyNCT04776395



Ignite Creation Date: 2024-05-06 @ 3:50 PM
Last Modification Date: 2024-10-26 @ 1:58 PM
Study NCT ID: NCT04776395
Status: RECRUITING
Last Update Posted: 2024-07-15
First Post: 2021-02-11

Brief Title: Iberdomide Alone or in Combination with Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma
Sponsor: Emory University
Organization: Emory University

Organization Data

Organization: Emory University
Class: OTHER
Study ID: STUDY00001731
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Emory University
Lead Sponsor Class: OTHER
Responsible Party: Nisha Joseph
Responsible Party Title: Principal Investigator
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation: Emory University
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH
Bristol-Myers Squibb INDUSTRY